Johan Renes

Person

Amersfoort, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Multi-specific binding molecules targeting aberrant cells
- Patent number 11,098,115
- Issue date Aug 24, 2021
- APO-T B.V.
- Ralph Alexander Willemsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aberrant cell-restricted immunoglobulins provided with a toxic moiety
- Patent number 10,946,104
- Issue date Mar 16, 2021
- APO-TB.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polypeptide that binds aberrant cells and induces apoptosis
- Patent number 9,821,073
- Issue date Nov 21, 2017
- APO-T B.V.
- Ralph Alexander Willemsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mortgage insurance system
- Patent number 8,301,469
- Issue date Oct 30, 2012
- Mark Veldhuizen
- G06 - COMPUTING CALCULATING COUNTING

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS
- Publication number 20230046744
- Publication date Feb 16, 2023
- APO-T B.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS
- Publication number 20210355209
- Publication date Nov 18, 2021
- APO-T B.V.
- Ralph Alexander Willemsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS
- Publication number 20210238543
- Publication date Aug 5, 2021
- APO-T B.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
- Publication number 20210205465
- Publication date Jul 8, 2021
- APO-T B.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES TARGETING PATHOGENS
- Publication number 20200339669
- Publication date Oct 29, 2020
- APO-T B.V.
- Johan Renes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
- Publication number 20180154013
- Publication date Jun 7, 2018
- APO-T B.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES TARGETING PATHOGENS
- Publication number 20180105587
- Publication date Apr 19, 2018
- APO-T B.V.
- Johan Renes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS
- Publication number 20180071398
- Publication date Mar 15, 2018
- APO-T B.V.
- Ralph Alexander Willemsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
- Publication number 20150202318
- Publication date Jul 23, 2015
- APO-T B.V.
- JOHAN RENES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES TARGETING PATHOGENS
- Publication number 20150175683
- Publication date Jun 25, 2015
- APO-T B.V.
- Johan Renes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
- Publication number 20150056198
- Publication date Feb 26, 2015
- APO-T B.V.
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Means for Clinical Investigations
- Publication number 20140336475
- Publication date Nov 13, 2014
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS
- Publication number 20140227273
- Publication date Aug 14, 2014
- APO-TB.V.
- Ralph Alexander Willemsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS
- Publication number 20140205599
- Publication date Jul 24, 2014
- Ralph Alexander Willemsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
- Publication number 20130183307
- Publication date Jul 18, 2013
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION INSURANCE SYSTEM
- Publication number 20130046564
- Publication date Feb 21, 2013
- Mark Veldhuizen
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
Methods and means for clinical investigations
- Publication number 20120123218
- Publication date May 17, 2012
- JPWaVe BV
- Johan Renes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-BETA STRUCTURES AS CARRIER IN VACCINES
- Publication number 20110287047
- Publication date Nov 24, 2011
- Crossbeta Biosciences B.V.
- Barend Bouma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS
- Publication number 20110052564
- Publication date Mar 3, 2011
- Martijn Frans Ben Gerard Gebbink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGENIC COMPOSITIONS CAPABLE OF ACTIVATING T-CELLS
- Publication number 20110008376
- Publication date Jan 13, 2011
- Martijn Frans Ben Gerard Gebbink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunogenic compositions capable of activating T-cells
- Publication number 20090191228
- Publication date Jul 30, 2009
- Crossbeta Biosciences B.V.
- Martijn Frans Ben Gerard Gebbink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunogenic compositions
- Publication number 20090142377
- Publication date Jun 4, 2009
- Crossbeta Biosciences B.V.
- Martijn Frans Ben Gerard Gebbink
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Johan Renes

Person

Patents Grantslast 30 patents

Multi-specific binding molecules targeting aberrant cells

Aberrant cell-restricted immunoglobulins provided with a toxic moiety

Polypeptide that binds aberrant cells and induces apoptosis

Mortgage insurance system

Patents Applicationslast 30 patents

METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS

MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS

METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

BINDING MOLECULES TARGETING PATHOGENS

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

BINDING MOLECULES TARGETING PATHOGENS

POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

BINDING MOLECULES TARGETING PATHOGENS

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

Methods and Means for Clinical Investigations

MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS

POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS

ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY

SEPARATION INSURANCE SYSTEM

Methods and means for clinical investigations

CROSS-BETA STRUCTURES AS CARRIER IN VACCINES

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

IMMUNOGENIC COMPOSITIONS CAPABLE OF ACTIVATING T-CELLS

Immunogenic compositions capable of activating T-cells

Immunogenic compositions